The following list of speakers have confirmed their attendance. This list will be updated regularly in the months before the conference.

Confirmed Speakers (in alphabetical order)

Dr. Hugo de Waal

Head of School of Psychiatry,Health Education East of England

Consultant Old Age Psychiatrist, Norfolk and Suffolk NHS Foundation Trust

Senior Lecturer (hon), University of East Anglia School of Medicine, Health Policy and Practice

Dr Hugo de WaalDr de Waal gained his MD at the Free University of Amsterdam (1989), following which he trained in the UK, becoming a Consultant in Norfolk in 1998. From March 2003 until April 2010 he was Coordinating Tutor for the Norfolk Training Scheme. In 2004 he started Norfolk’s own MRCPsych and after a few years he revamped the course, adopting Problem-Based Learning as the main learning method. He adapted this method for the purposes of postgraduate medical education and this course has seen pass rates of the Royal College membership consistently at around double the average national pass rate.
At the end of 2007 Dr de Waal was appointed Head of School of the fourth largest postgraduate school of psychiatry in the UK. The role was redesigned ‘post-Darzi’: he is now Associate Postgraduate Dean for Psychiatry for the East of England. He is a Fellow of the Royal College of Psychiatrists and a Fellow of the Higher Education Academy. 

Currently he is seconded to the Maudsley to review and reconfigure its community services for older people and 'onwards seconded' as Clinical Director for the dementia theme of the South London Health Innovation Network.

Dr. Emilio Fernandez-Egea

Senior Research Associate, Department of Psychiatry, University of Cambridge

Consultant in General Adult Psychiatry, Cambridgeshire and Peterborough NHS Foundation Trust

Emilio  Fernandez-EgeaMy research interests are mostly the biological and clinical aspects of chronic schizophrenia. I’m the Clozapine Clinic Lead and the Good Outcome Schizophrenia Clinic lead for the local MH Trust (Cambridgeshire and Peterborough NHS Foundation Trust). We are now involved in several studies looking at subjects suffering with treatment resistant schizophrenia from different angles. These include studies on biomarkers (metabolism, immunity and inflammation), genetics, neuroimaging, clinical epidemiology, interaction between physical and mental health and clinical trials with new interventions (both pharmacological and non-pharmacological).

Prof. Paul Fletcher

Bernard Wolfe Professor of Health Neuroscience, University of Cambridge

Paul FletcherI am interested in psychosis. I agree with the long tradition of clinical psychiatric research which suggests that, during a psychotic illness, the world is a strange place because strange associations are formed and inconsequential stimuli are assigned undue weight. This can be extremely unpleasant. I think that, if we can understand the brain basis for how associations are made and how we come to think of particular environmental stimuli as important, then perhaps we can apply this to understanding psychotic symptoms such as delusions, hallucinations and thought disorder.

I use combined functional neuroimaging and pharmacological experiments together with studies with patients in order to explore the extent to which such symptoms may be related to deficits in basic learning processes.

Dr. Neil Hunt

Consultant in General Adult Psychiatry, Cambridgeshire and Peterborough NHS Foundation Trust

Dr. Hunt has a particular interest in Bipolar disorder. He wrote his MD thesis on 'the causes of recurrence in Bipolar Affective Disorder".  A copy of this thesis is lodged in the library of St Bartholomew's Hospital in London. He has written regularly in the newsletters for the local branch of BipolarUK in Cambridge about subjects from the nature of the illness through to aspects of treatment. 

Dr Hunt is also an Associate Lecturer at the clinical school of the University of Cambridge. He lectures on the clinical course in psychiatry for medical students, particularly about effective treatment for mental disorders. He also teaches students on the wards and in the clinics and examines them in their end of course assessments.

Dr Hunt has been providing specialist psychiatric medico legal reports for more than 15 years. These have been for both criminal and civil matters and he has appeared in court as an expert witness when required. He is a founder member of the Society of Expert Witnesses and has been trained in the reforms in the civil procedure rules.

Prof. Peter Jones

Head of Department. Department of Psychiatry. University of Cambridge

Peter JonesThe Cambridge “epiCentre” group works at the interface between population-based research, neuroscience and clinical psychiatry in order to understand the causes, mechanisms and treatments for psychosis (particularly schizophrenia) dementia, depression and bipolar disorder.

We investigate classical epidemiological characteristics in order to uncover causes, and have particular interests in cognition, longitudinal data and novel modelling approaches to defining life course descriptions of disorders and psychological dimensions in the population that we believe are stronger phenotypes for aetiological, genetic and treatment research than traditional approaches.

We have many local and international collaborators, particularly with the University of Oulu, Finland, and the MRC LHA unit. We have a strong partnership with the local clinical service for first episode psychosis, CAMEO (www.cameo.nhs.uk).

Dr. Manaan Kar-Ray

Clinical Director of Acute Care Services. Cambridgeshire and Peterborough NHS Foundation Trust

I am a General Adult Consultant Psychiatrist based in Cambridge and the Clinical Director for Acute Care Mental Health within Cambridgeshire and Peterborough NHS Foundation  Trust. I trained in Oxford (both basic and specialist). My private clinic as a Consultant Psychiatrist is at Fitzwilliam Hospital, Peterborough.  I have a specific clinical and research interest in mood disorders and psychosis and have extensive experience of working with complex and resistant cases. I have a sub-speciality accreditation in Rehabilitation Psychiatry. 

Dr. Joanna Moncrieff

Senior Clinical Lecturer. Mental Health Sciences Unit. University College London

My research consists of an analysis of all aspects of psychiatric drug treatment, including subjective experiences, history of drug treatment, a critique of evidence for drug treatments, theoretical perspectives on psychiatric drug treatment, and political aspects of drug treatment, including work on the influence of the pharmaceutical industry. I am also interested in the nature and function of diagnosis in modern psychiatric practice, and in the history, politics and philosophy of psychiatry more generally. I have written two books: The Myth of the Chemical Cure, published by Palgrave Macmillan and A Straight Talking Introduction to Psychiatric Drugs, published by PCCs books.

Dr. Jesus Perez

Consultant Psychiatrist, CAMEO Early Intervention Service, Fulbourn Hospital

Associate Lecturer, Department of Psychiatry, University of Cambridge

Director of the West Anglia Comprehensive Local Research Network, National Institute for Health Research

Jesus Perez
My research activity is mainly focused on early detection and intervention in psychosis and the history of psychiatry. I am particularly interested in the epidemiological aspects of young people at high-risk of developing psychosis and with first-episode psychosis. This includes clinical antecedents and sociodemographic characteristics of these populations. I am also keen in understanding the factors associated with diagnostic stability of first-episode psychotic disorders, especially first-episode mania. Part of my research is dedicated to service development within the NHS.

I am the Lead Consultant Psychiatrist for Cameo Early Intervention in Psychosis Services; former Director of the East Anglia Hub and Member of the 2 As (Advisory and Allocation) National Committee of the Mental Health Research Network.

Dr. Annabel Price

Consultant Liaison Psychiatrist, Addenbrooke’s Hospital

Visiting Researcher, Department of Psychiatry, University of Cambridge

Annabel is a Consultant Liaison Psychiatrist in the Older People's Service at Addenbrooke's Hospital. She has a research interest in mental health at the end of life and has published on various aspects of this including the epidemiology of depression in palliative care. Her PhD focuses on mental capacity for terminally ill patients requesting assisted suicide.